Persistence of Hepatocellular Carcinoma Risk after Hepatitis C Virus Eradication

Persistence of Hepatocellular Carcinoma Risk after Hepatitis C Virus Eradication

Bibliographic Details
Main Authors:	Sojung Han, Jun Yong Park
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2020-05-01
Series:	The Korean Journal of Gastroenterology
Online Access:	http://www.kjg.or.kr/journal/view.html?uid=5582&vmd=Full

Similar Items

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
by: Roberta D’Ambrosio, et al.
Published: (2021-09-01)

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
by: Nobuharu Tamaki, et al.
Published: (2022-03-01)

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
by: Natsumi Oe, et al.
Published: (2022-04-01)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
by: Hye Won Lee, et al.
Published: (2020-11-01)

Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
by: Shih-Jer Hsu, et al.
Published: (2020-01-01)

Mixed Cryoglobulinaemia Vasculitis after Persistent Hepatitis C Virus Eradication
by: Margarida Gaudêncio, et al.
Published: (2021-08-01)

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
by: Hiroyuki Motoyama, et al.
Published: (2018-01-01)

The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C
by: Hidenori Toyoda, et al.
Published: (2022-01-01)

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
by: Masato Nakai, et al.
Published: (2022-01-01)

Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
by: Hiroyuki Motoyama, et al.
Published: (2018-01-01)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
by: Thomas F. Baumert, et al.
Published: (2019-05-01)

Hepatitis C Virus and Hepatocellular Carcinoma
by: Masao Omata, et al.
Published: (2013-01-01)

Hepatitis C virus to hepatocellular carcinoma
by: Jahan Shah, et al.
Published: (2012-01-01)

Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Nevin Varghese, et al.
Published: (2024-02-01)

Hepatitis C virus and hepatocellular carcinoma Hepatitis por virus C y carcinoma hepatocelular
by: Antonio Garrido-Serrano, et al.
Published: (2011-05-01)

Hepatitis C virus-induced hepatocellular carcinoma
by: Nicolas Goossens, et al.
Published: (2015-06-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

The Challenging Road to Hepatitis C Virus Eradication
by: Isidoro Martínez, et al.
Published: (2021-02-01)

Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.
by: Yuewen Han, et al.
Published: (2016-01-01)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
by: Jeong Won Jang, et al.
Published: (2021-01-01)

Hepatic Angiomyolipoma Mimicking Primary Hepatocellular Carcinoma
by: Min Seok Han, et al.
Published: (2016-11-01)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
by: Pil Soo Sung, et al.
Published: (2021-01-01)

The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
by: Feiyan Zhu, et al.
Published: (2021-04-01)

The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
by: Chia-Chi Wang, et al.
Published: (2021-03-01)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
by: Hae Won Yoo, et al.
Published: (2022-01-01)

Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C.
by: Annie Y Chen, et al.
Published: (2015-01-01)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
by: Xiaofei Li, et al.
Published: (2020-04-01)

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
by: Bruno S, et al.
Published: (2011-03-01)

The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01)

The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression
by: Ciniso Sylvester Shabangu, et al.
Published: (2021-10-01)

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
by: Hye Kyong Park, et al.
Published: (2019-08-01)

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
by: Sojung Han, et al.
Published: (2020-07-01)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
by: Anca Trifan, et al.
Published: (2023-02-01)

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
by: Luo Y, et al.
Published: (2020-07-01)

Hepatitis C and hepatocellular carcinoma
by: Eduardo Fassio
Published: (2010-01-01)

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
by: Yoshihiko Tachi, et al.
Published: (2015-01-01)

Hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
by: Camillo Porta
Published: (2011-12-01)

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Chia-I. Lin, et al.
Published: (2011-12-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
by: Young-Hwan Ahn, et al.
Published: (2022-09-01)